Longwood Capital Partners »

Tango Therapeutics shares owned by Longwood Capital Partners

Quarter-by-quarter ownership of Tango Therapeutics (TNGX) shares owned by Longwood Capital Partners from 13F filings

Historical chart of Longwood Capital Partners investment in Tango Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tango Therapeutics held by Longwood Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tango Therapeutics by Longwood Capital Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.5M 283k 8.86

More positions owned by Longwood Capital Partners

Terns Pharmaceuticals (TERN)
Praxis Precision Medicines I (PRAX)
Cidara Therapeutics Com New (CDTX)
Ocular Therapeutix (OCUL)
Aadi Bioscience (WHWK)
Bright Minds Biosciences Com New (DRUG)
Compass Therapeutics (CMPX)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Insmed Com Par $.01 (INSM)
Argen Se - Sponsored Adr (ARGX)
Surrozen Com New (SRZN)
Amylyx Pharmaceuticals (AMLX)
Minerva Neurosciences Com New (NERV)
Tango Therapeutics (TNGX)
Taysha Gene Therapies Com Shs (TSHA)

View all positions for Longwood Capital Partners

Top funds holding Tango Therapeutics

Farallon Capital Management
Woodline Partners
Boxer Capital Management
TCG Crossover Management
Trv Gp Iv
Vanguard Group
State Street Corporation
Siren
BlackRock
Nextech Invest
Goldman Sachs Group
Gilead Sciences
Logos Global Management
Bellevue Group
Caligan Partners

View all funds holding Tango Therapeutics